Lord, Abbett & Co’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-416,358
Closed -$22M 913
2017
Q2
$22M Sell
416,358
-117,396
-22% -$6.29M 0.07% 428
2017
Q1
$29.7M Sell
533,754
-90,865
-15% -$5.01M 0.09% 343
2016
Q4
$32.5M Buy
624,619
+9,590
+2% +$463K 0.1% 297
2016
Q3
$29.7M Sell
615,029
-799,590
-57% -$40.4M 0.09% 351
2016
Q2
$78.4M Sell
1,414,619
-162,008
-10% -$8.92M 0.25% 104
2016
Q1
$84.2M Sell
1,576,627
-161,001
-9% -$7.93M 0.26% 102
2015
Q4
$89.5M Sell
1,737,628
-568,696
-25% -$28.3M 0.27% 85
2015
Q3
$104M Buy
2,306,324
+415,532
+22% +$19.6M 0.31% 66
2015
Q2
$87.4M Buy
1,890,792
+1,074,191
+132% +$47M 0.23% 112
2015
Q1
$35M Buy
+816,601
New +$31.1M 0.09% 351

Other funds holding PBH

Lord, Abbett & Co's PBH Position: Q3 2017 in Review

Lord, Abbett & Co sold out of Prestige Consumer Healthcare (PBH) in Q3 2017, closing a stake of 416,358 shares — an estimated $22M sold.

Lord, Abbett & Co first reported a position in PBH in Q1 2015 and held it in 10 quarters. The position peaked at $104M in Q3 2015. 239 funds tracked by Wall St. Rank hold PBH as of Q3 2017.

  • Lord, Abbett & Co reported no remaining Prestige Consumer Healthcare position as of Q3 2017 after selling out during the quarter.
  • Lord, Abbett & Co sold 416,358 Prestige Consumer Healthcare shares in Q3 2017, an estimated $22M.
  • Lord, Abbett & Co first reported a position in Prestige Consumer Healthcare in Q1 2015 and held it in 10 quarters.
  • Lord, Abbett & Co's Prestige Consumer Healthcare position peaked at $104M in Q3 2015.
  • 239 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2017.

Based on Lord, Abbett & Co's 13F filing for Q3 2017, filed 14 Nov 2017.